🌎 ESAB Initiated, Samsara Initiated, TransUnion Upgraded and more…
RJ Hamster
Ratings changes for Enphase Energy, SolarEdge Technologies, Esperion Therapeutics, Micron Technology, Ocular Therapeutix, Iovance Biotherapeutics, United Therapeutics and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports.Learn More.
Meta Platforms (NASDAQ:META) had its price target raised by analysts at KeyCorp () from $475.00 to $540.00. They now have an “overweight” rating on the stock. This represents a 7.9% upside from the current price of $500.52.
ASM International (OTCMKTS:ASMIY) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating.The current price is $757.65.
Bread Financial (NYSE:BFH) was upgraded by analysts at Evercore ISI from an “underperform” rating to an “in-line” rating. They now have a $45.00 price target on the stock, up previously from $42.00. This represents a 3.7% upside from the current price of $43.41.
DLocal (NASDAQ:DLO) was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating. They now have a $9.00 price target on the stock, down previously from $13.00. This represents a 21.1% upside from the current price of $7.43.
First Quantum Minerals (OTCMKTS:FQVLF) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating.The current price is $12.12.
HomeStreet (NASDAQ:HMST) was upgraded by analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating. They now have a $13.50 price target on the stock. This represents a 22.4% upside from the current price of $11.03.
iRhythm Technologies (NASDAQ:IRTC) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $115.00 price target on the stock. This represents a 9.8% upside from the current price of $104.78.
Ocular Therapeutix (NASDAQ:OCUL) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $11.00 price target on the stock, up previously from $7.00. This represents a 83.0% upside from the current price of $6.01.
Skyworks Solutions (NASDAQ:SWKS) was upgraded by analysts at B. Riley from a “neutral” rating to a “buy” rating. They now have a $130.00 price target on the stock, up previously from $96.00. This represents a 21.0% upside from the current price of $107.42.
TransUnion (NYSE:TRU) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $92.00 price target on the stock. This represents a 24.4% upside from the current price of $73.97.
Williams Companies (NYSE:WMB) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating.The current price is $42.51.
British Land (OTCMKTS:BTLCY) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating.The current price is $5.41.
Deutsche Lufthansa (OTCMKTS:DLAKY) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating.The current price is $6.47.
Esperion Therapeutics (NASDAQ:ESPR) was downgraded by analysts at Bank of America Co. from a “neutral” rating to an “underperform” rating. They now have a $2.50 price target on the stock, down previously from $2.90. This represents a 1.6% upside from the current price of $2.46.
Prelude Therapeutics (NASDAQ:PRLD) was downgraded by analysts at Barclays PLC from an “equal weight” rating to an “underweight” rating. They now have a $3.00 price target on the stock. This represents a 19.8% downside from the current price of $3.74.
Ryanair (NASDAQ:RYAAY) was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating.The current price is $114.98.
Wärtsilä Oyj Abp (OTCMKTS:WRTBY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating.The current price is $4.44.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating. They now have a $5.00 price target on the stock, down previously from $28.00. This represents a 10.2% downside from the current price of $5.57.
Birkenstock (NYSE:BIRK) is now covered by analysts at BNP Paribas. They set an “outperform” rating and a $68.00 price target on the stock. This represents a 10.7% upside from the current price of $61.43.
ESAB (NYSE:ESAB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $115.00 price target on the stock. This represents a 19.2% upside from the current price of $96.49.
Samsara (NYSE:IOT) is now covered by analysts at Bank of America Co.. They set a “buy” rating and a $37.00 price target on the stock. This represents a 25.4% upside from the current price of $29.50.
Vericel (NASDAQ:VCEL) is now covered by analysts at TD Cowen. They set a “buy” rating and a $55.00 price target on the stock. This represents a 22.8% upside from the current price of $44.79.
Virios Therapeutics (NASDAQ:VIRI) is now covered by analysts at Maxim Group. They set a “buy” rating and a $1.00 price target on the stock. This represents a 311.2% upside from the current price of $0.24.
Vodafone Group Public (NASDAQ:VOD) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating on the stock.The current price is $9.08.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
